216 related articles for article (PubMed ID: 17343665)
21. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
van Westreenen HL; Cobben DC; Jager PL; van Dullemen HM; Wesseling J; Elsinga PH; Plukker JT
J Nucl Med; 2005 Mar; 46(3):400-4. PubMed ID: 15750150
[TBL] [Abstract][Full Text] [Related]
22. Selected cases demonstrating the value of furosemide-primed 18F-FDG PET in identifying adrenal involvement.
Nair N; Basu S
J Nucl Med Technol; 2005 Sep; 33(3):166-71. PubMed ID: 16145224
[TBL] [Abstract][Full Text] [Related]
23. FDG-PET imaging in primary bilateral adrenal lymphoma: a case report and review of the literature.
Kumar R; Xiu Y; Mavi A; El-Haddad G; Zhuang H; Alavi A
Clin Nucl Med; 2005 Apr; 30(4):222-30. PubMed ID: 15764875
[TBL] [Abstract][Full Text] [Related]
24. PET imaging of primary mediastinal tumours.
Kubota K; Yamada S; Kondo T; Yamada K; Fukuda H; Fujiwara T; Ito M; Ido T
Br J Cancer; 1996 Apr; 73(7):882-6. PubMed ID: 8611400
[TBL] [Abstract][Full Text] [Related]
25. Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation.
Caoili EM; Korobkin M; Brown RK; Mackie G; Shulkin BL
Acad Radiol; 2007 Apr; 14(4):468-75. PubMed ID: 17368217
[TBL] [Abstract][Full Text] [Related]
26. The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies.
Tian J; Chen L; Wei B; Shao M; Ding Y; Yin D; Yao S
Nucl Med Commun; 2004 Aug; 25(8):825-31. PubMed ID: 15266178
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of
Cook GJR; Lovat E; Siddique M; Goh V; Ferner R; Warbey VS
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1845-1852. PubMed ID: 28589254
[TBL] [Abstract][Full Text] [Related]
28. PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET.
Watanabe H; Inoue T; Shinozaki T; Yanagawa T; Ahmed AR; Tomiyoshi K; Oriuchi N; Tokunaga M; Aoki J; Endo K; Takagishi K
Eur J Nucl Med; 2000 Oct; 27(10):1509-17. PubMed ID: 11083540
[TBL] [Abstract][Full Text] [Related]
29. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings.
Stahl A; Ott K; Weber WA; Becker K; Link T; Siewert JR; Schwaiger M; Fink U
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):288-95. PubMed ID: 12552348
[TBL] [Abstract][Full Text] [Related]
30. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis.
Suzuki A; Kawano T; Takahashi N; Lee J; Nakagami Y; Miyagi E; Hirahara F; Togo S; Shimada H; Inoue T
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1413-20. PubMed ID: 15205922
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Musholt TJ; Musholt PB; Dehdashti F; Moley JF
Surgery; 1997 Dec; 122(6):1049-60; discussion 1060-1. PubMed ID: 9426419
[TBL] [Abstract][Full Text] [Related]
32. 2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in characterization of solid renal masses.
Kumar R; Chauhan A; Lakhani P; Xiu Y; Zhuang H; Alavi A
Mol Imaging Biol; 2005; 7(6):431-9. PubMed ID: 16307216
[TBL] [Abstract][Full Text] [Related]
33. Enhancing the clinical diagnosis of the acute and subacute phases of autoimmune encephalitis and predicting the risk factors: the potential advantages of 18F-FDG PET/CT.
Liu L; Lyu Z; Li H; Bai L; Wan Y; Li P
BMC Med Imaging; 2023 Nov; 23(1):193. PubMed ID: 37986052
[TBL] [Abstract][Full Text] [Related]
34. FDG-PET scanning in the diagnosis of gastrointestinal cancers.
van Kouwen MC; Oyen WJ; Nagengast FM; Jansen JB; Drenth JP
Scand J Gastroenterol Suppl; 2004; (241):85-92. PubMed ID: 15696855
[TBL] [Abstract][Full Text] [Related]
35. 18F-FDG PET in detecting metastatic infectious disease.
Bleeker-Rovers CP; Vos FJ; Wanten GJ; van der Meer JW; Corstens FH; Kullberg BJ; Oyen WJ
J Nucl Med; 2005 Dec; 46(12):2014-9. PubMed ID: 16330565
[TBL] [Abstract][Full Text] [Related]
36. The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.
Kaira K; Sunaga N; Ishizuka T; Shimizu K; Yamamoto N
Cancer Imaging; 2011 Nov; 11(1):195-201. PubMed ID: 22138614
[TBL] [Abstract][Full Text] [Related]
37. Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours?
Hain SF; O'Doherty MJ; Bingham J; Chinyama C; Smith MA
Nucl Med Commun; 2003 Nov; 24(11):1139-43. PubMed ID: 14569167
[TBL] [Abstract][Full Text] [Related]
38. The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study.
Chang TC; Yen TC; Li YT; Wu YC; Chang YC; Ng KK; Jung SM; Wu TI; Lai CH
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):156-63. PubMed ID: 16220307
[TBL] [Abstract][Full Text] [Related]
39. Schwannoma of the extremities: the role of PET in preoperative planning.
Ahmed AR; Watanabe H; Aoki J; Shinozaki T; Takagishi K
Eur J Nucl Med; 2001 Oct; 28(10):1541-51. PubMed ID: 11685498
[TBL] [Abstract][Full Text] [Related]
40. High 18F-Fluorodeoxyglucose Uptake in Adrenal Angiomyolipoma: Case Report and Review of Literature.
Li W; Pang H; Cao Y; Guan L; Chen J
Medicine (Baltimore); 2015 Jun; 94(22):e900. PubMed ID: 26039121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
